These results suggested that ZNF350 is a potential predictor of poor prognosis in patients with glioma, greatly promotes the growth of glioma cells in vitro, and mediates the positive regulation of HECW1 on NCOA4. This evidence concerns the gene ZNF350 and central nervous system cancer.